Arakoda, an 8-aminoquinolone antimalarial, was approved in 2018 for the prophylaxis of malaria in patients aged 18 years and older.

Individuals with recall related inquiries can contact Amneal Pharmaceuticals at (833) 582-0812 or via email at [email protected]. Adverse reactions should be reported to ...

The approval was supported by data from the randomized, double-blind, placebo-controlled, phase 3 ARANOTE trial.

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

Findings seen in women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for HR-positive breast cancer.

The FDA is expected to decide on treatments for multiple myeloma, NSCLC, melanoma, phenylketonuria, and 2 rare kidney diseases.

Inverse correlation seen for arterial flow mediated dilation with smoking frequency and amount of THC ingested.